Literature DB >> 18533732

Intercalation of daunomycin into stacked DNA base pairs. DFT study of an anticancer drug.

G Barone1, C F Guerra, N Gambino, A Silvestri, A Lauria, A M Almerico, F M Bickelhaupt.   

Abstract

We have computationally studied the intercalation of the antitumor drug daunomycin into six stacks of Watson-Crick DNA base pairs (i.e., AT-AT, AT-TA, GC-AT, CG-TA, GC-GC, GC-CG) using density functional theory (DFT). The proton affinity of the DNA intercalator daunomycin in water was computed to be 159.2 kcal/mol at BP86/TZ2P, which is in line with the experimental observation that daunomycin is protonated under physiological conditions. The intercalation interaction of protonated daunomycin with two stacked DNA base pairs was studied through a hybrid approach in which intercalation is treated at LDA/TZP while the molecular structure of daunomycin and hydrogen-bonded Watson-Crick pairs is computed at BP86/TZ2P. We find that the affinity of the drug for the six considered base pair dimers decreases in the order AT-AT > AT-TA > GC-AT > GC-TA > GC-CG > GC-GC, in excellent agreement with experimental data on the thermodynamics of the interaction between daunomycin and synthetic polynucleotides in aqueous solution. Our analyses show that the overall stability of the intercalation complexes comes mainly from pi-pi stacking but an important contribution to the computed and experimentally observed sequence specificity comes from hydrogen bonding between daunomycin and hetero atoms in the minor groove of AT base pairs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18533732     DOI: 10.1080/07391102.2008.10507229

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  8 in total

1.  Binding of anticancer drug daunomycin to a TGGGGT G-quadruplex DNA probed by all-atom molecular dynamics simulations: additional pure groove binding mode and implications on designing more selective G-quadruplex ligands.

Authors:  Zhanhang Shen; Kelly A Mulholland; Yujun Zheng; Chun Wu
Journal:  J Mol Model       Date:  2017-08-08       Impact factor: 1.810

2.  Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy.

Authors:  Robert L Haining; Travis M Jones; Aubrey Hernandez
Journal:  Neurochem Res       Date:  2016-09-23       Impact factor: 3.996

Review 3.  microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview.

Authors:  Martino Marco Gabra; Leonardo Salmena
Journal:  Front Oncol       Date:  2017-10-30       Impact factor: 6.244

Review 4.  Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance.

Authors:  Ajaz A Bhat; Salma N Younes; Syed Shadab Raza; Lubna Zarif; Sabah Nisar; Ikhlak Ahmed; Rashid Mir; Sachin Kumar; Surender K Sharawat; Sheema Hashem; Imadeldin Elfaki; Michal Kulinski; Shilpa Kuttikrishnan; Kirti S Prabhu; Abdul Q Khan; Santosh K Yadav; Wael El-Rifai; Mohammad A Zargar; Hatem Zayed; Mohammad Haris; Shahab Uddin
Journal:  Mol Cancer       Date:  2020-03-12       Impact factor: 27.401

5.  Topoisomerases inhibition and DNA binding mode of daunomycin-oligoarginine conjugate.

Authors:  Valeria Visone; Ildikó Szabó; Giuseppe Perugino; Ferenc Hudecz; Zoltán Bánóczi; Anna Valenti
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

6.  Graphene quantum dots mediated electron transfer in DNA base pairs.

Authors:  Chang Liu; Linqing Guo; Biao Zhang; Liping Lu
Journal:  RSC Adv       Date:  2019-10-04       Impact factor: 4.036

7.  Absorption Properties of Large Complex Molecular Systems: The DFTB/Fluctuating Charge Approach.

Authors:  Piero Lafiosca; Sara Gómez; Tommaso Giovannini; Chiara Cappelli
Journal:  J Chem Theory Comput       Date:  2022-02-20       Impact factor: 6.006

8.  B-DNA Structure and Stability as Function of Nucleic Acid Composition: Dispersion-Corrected DFT Study of Dinucleoside Monophosphate Single and Double Strands.

Authors:  Giampaolo Barone; Célia Fonseca Guerra; F Matthias Bickelhaupt
Journal:  ChemistryOpen       Date:  2013-08-16       Impact factor: 2.911

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.